Ben Fidler
@benthefidler
Biotech Journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy.
ID: 1330055544
https://www.biopharmadive.com 05-04-2013 20:58:03
7,7K Tweet
8,8K Takipçi
608 Takip Edilen
Vor, with new CEO, changes course to target autoimmune disease biopharmadive.com/news/vor-remeg… by Gwendolyn Wu $VOR